Corvus Pharmaceuticals, Inc. (CRVS)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch CRVS
See up to 3 months of CRVS. The 7-day demo opens the 1M and 3M ranges and puts CRVS on your watchlist.
Start 7-day demoLatest CRVS insider trades
About Corvus Pharmaceuticals, Inc. (CRVS)
Corvus Pharmaceuticals, Inc. is an SEC registrant, filing under CIK 0001626971, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
CRVS Form 4 activity by transaction type, last 90 days
No Form 4 activity for CRVS in the last 90 days.
CRVS insider transactions (Form 4)
4816 Form 4 filings on record, the earliest from Dec 23, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David Scott Moore | Open-market purchase | Common Stock | 21,700 | $11.53 | $250K | |
| David Scott Moore | Grant or award | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Ian T. Clark | Grant or award | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Linda Grais | Grant or award | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
 Peter A. Thompson | Grant or award | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Den Broek Richard van | Grant or award | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Richard A. Md Miller - Officer | Open-market purchase | Common Stock | 5,000 | $12.05 | $60K | |
| Richard A. Md Miller - Officer | Open-market purchase | Common Stock | 1,932 | $12.01 | $23K | |
 Andrew C. Chan | Grant or award | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Peter A. Thompson - Director | Option exercise | Common Stock | 30,000 | $15.00 | $450K | |
| Peter A. Thompson - Director | Option exercise | Common Stock | 15,000 | $9.70 | $146K | |
| Peter A. Thompson - Director | Option exercise | Common Stock | 15,000 | $12.50 | $188K | |
| Peter A. Thompson - Director | Option exercise | Common Stock | 15,000 | $3.61 | $54K | |
| Peter A. Thompson - Director | Option exercise | Common Stock | 15,000 | $2.00 | $30K | |
| Peter A. Thompson - Director | Option exercise | Common Stock | 15,000 | $3.27 | $49K | |
| Peter A. Thompson - Director | Option exercise | Common Stock | 15,000 | $2.74 | $41K | |
| Peter A. Thompson - Director | Option exercise | Common Stock | 15,000 | $2.60 | $39K | |
| Peter A. Thompson - Director | Option exercise | Common Stock | 15,000 | $0.99 | $15K | |
| Peter A. Thompson - Director | Option exercise | Common Stock | 15,000 | $2.49 | $37K | |
| Peter A. Thompson - Director | Option exercise | Common Stock | 15,000 | $0.97 | $14K | |
| Peter A. Thompson - Director | Option exercise | Common Stock | 15,000 | $1.64 | $25K | |
| Peter A. Thompson - Director | Option exercise | Common Stock | 15,000 | $2.12 | $32K | |
| Peter A. Thompson - Director | Option exercise | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Peter A. Thompson - Director | Option exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Peter A. Thompson - Director | Option exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Peter A. Thompson - Director | Option exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Peter A. Thompson - Director | Option exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Peter A. Thompson - Director | Option exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Peter A. Thompson - Director | Option exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Peter A. Thompson - Director | Option exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Peter A. Thompson - Director | Option exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Peter A. Thompson - Director | Option exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Peter A. Thompson - Director | Option exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Peter A. Thompson - Director | Option exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Peter A. Thompson - Director | Option exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| David Scott Moore | Grant or award | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Peter A. Thompson - Director | Other | Common Stock | 1,397,684 | $3.50 | $4.89M | |
| Peter A. Thompson - Director | Open-market sale | Common Stock | 1,176,332 | $4.16 | $4.89M | |
| Peter A. Thompson - Director | Other | Common Warrants (right to buy) | 1,397,684 | $0.00 | - | |
| ORBIMED ADVISORS LLC - Director | Other | Common Stock | 1,397,684 | $3.50 | $4.89M | |
| ORBIMED ADVISORS LLC - Director | Open-market sale | Common Stock | 1,176,332 | $4.16 | $4.89M | |
| ORBIMED ADVISORS LLC - Director | Other | Common Warrants (right to buy) | 1,397,684 | $0.00 | - | |
| Richard A. Md Miller - Officer | Option exercise | Common Stock | 559,073 | $3.50 | $1.96M | |
| Richard A. Md Miller - Officer | Option exercise | Warrant (Right to Buy) | 559,073 | - | - | |
| Jeffrey Arcara - Officer | Grant or award | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| William Benton Jones - Officer | Grant or award | Stock Option (Right to Buy) | 300,000 | $0.00 | - | |
| Leiv Lea - Officer | Grant or award | Stock Option (Right to Buy) | 300,000 | $0.00 | - | |
| Richard A. Md Miller - Officer | Grant or award | Stock Option (Right to Buy) | 750,000 | $0.00 | - |
Item 2.02, 9.01
Item 5.02
Item 5.07
Item 7.01, 8.01, 9.01
CRVS insider trading FAQ
What is the latest insider trade for CRVS?
Corvus Pharmaceuticals, Inc. (CRVS) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-15. The full record for CRVS runs to 16 Form 4 filings, the earliest from 2024-12-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CRVS stock?
No insider purchases of CRVS were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling CRVS stock?
No insider sales of CRVS were filed in the last 90 days. 2 sales are on record for this company.
Where can I see CRVS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CRVS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - David Scott Moore view on EDGAR
- - Ian T. Clark view on EDGAR
- - Linda Grais view on EDGAR
- - Peter A. Thompson view on EDGAR
- - Den Broek Richard van view on EDGAR
- - Richard A. Md Miller view on EDGAR
- - Andrew C. Chan view on EDGAR
- - Peter A. Thompson view on EDGAR
- - David Scott Moore view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CRVS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CRVS with a 7-day demo
- CRVS on your watchlist
- Every CRVS Form 4 filing on record
- Up to 3 months of CRVS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
